Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and BTB domain-containing protein 2 (ZBTB2) is a member of the BTB/POZ family of transcription factors that acts primarily as a transcriptional repressor. It contains zinc finger motifs mediating DNA binding and a BTB/POZ domain that facilitates protein-protein interactions. ZBTB2 represses genes within the ARF-HDM2-p53-p21 axis critical for cell cycle control, acting as a master regulator that can inhibit the cell cycle arrest function of p53 by direct DNA binding and interaction with transcription factors such as Sp1. ZBTB2 associates with chromatin-modifying complexes (including NuRD and HiRA) and regulates chromatin structure during stem cell differentiation and development. Dysregulation or abnormal expression of ZBTB2 is implicated in cancer biology as a potential proto-oncogene and is associated with certain inherited retinal degenerative diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain-containing protein 2 (ZBTB2).